Efficacy and Safety of Ivacaftor in Patients Aged 6 to 11 Years with Cystic Fibrosis with a G551D Mutation
…, CE Wainwright, GJ Canny, MA Chilvers… - American journal of …, 2013 - atsjournals.org
Rationale: Ivacaftor (VX-770), a cystic fibrosis transmembrane conductance regulator (CFTR)
potentiator, has been shown to improve lung function, pulmonary exacerbation rate, …
potentiator, has been shown to improve lung function, pulmonary exacerbation rate, …
Ciliary beat pattern is associated with specific ultrastructural defects in primary ciliary dyskinesia
MA Chilvers, A Rutman, C O'Callaghan - Journal of Allergy and Clinical …, 2003 - Elsevier
BACKGROUND: The main symptoms of primary ciliary dyskinesia (PCD) are nasal rhinorrhea
or blockage and moist-sounding cough. Diagnosis can be difficult and is based on an …
or blockage and moist-sounding cough. Diagnosis can be difficult and is based on an …
Diagnosis of primary ciliary dyskinesia. An official American Thoracic Society clinical practice guideline
…, M Rosenfeld, SD Dell, MA Chilvers… - American journal of …, 2018 - atsjournals.org
Background: This document presents the American Thoracic Society clinical practice
guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target Audience: Clinicians …
guidelines for the diagnosis of primary ciliary dyskinesia (PCD). Target Audience: Clinicians …
Analysis of ciliary beat pattern and beat frequency using digital high speed imaging: comparison with the photomultiplier and photodiode methods
MA Chilvers, C O'Callaghan - Thorax, 2000 - thorax.bmj.com
BACKGROUND The aim of this study was to determine the relationship of the power and
recovery stroke of respiratory cilia using digital high speed video imaging. Beat frequency …
recovery stroke of respiratory cilia using digital high speed video imaging. Beat frequency …
Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR: a randomised, placebo-controlled …
…, D Schaeffer, M Solomon, M Chilvers… - The lancet Respiratory …, 2017 - thelancet.com
Background Lumacaftor and ivacaftor combination treatment showed efficacy in patients
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …
aged 12 years or older with cystic fibrosis homozygous for F508del-cystic fibrosis …
Diagnostic testing of patients suspected of primary ciliary dyskinesia
WA Stannard, MA Chilvers, AR Rutman… - American journal of …, 2010 - atsjournals.org
Rationale: Electron microscopy (EM) of ciliated epithelium is widely used to diagnose primary
ciliary dyskinesia (PCD). Ciliary beat frequency (CBF) has been used to screen samples to …
ciliary dyskinesia (PCD). Ciliary beat frequency (CBF) has been used to screen samples to …
Inconclusive diagnosis of cystic fibrosis after newborn screening
…, M Boland, T Kovesi, C Bjornson, MA Chilvers… - …, 2015 - publications.aap.org
OBJECTIVES: To prospectively study infants with an inconclusive diagnosis of cystic fibrosis
(CF) identified by newborn screening (NBS; “CF screen positive, inconclusive diagnosis” […
(CF) identified by newborn screening (NBS; “CF screen positive, inconclusive diagnosis” […
Burkholderia Species Infections in Patients with Cystic Fibrosis in British Columbia, Canada. 30 Years' Experience
…, TJ Hird, E Mahenthiralingam, MA Chilvers… - Annals of the …, 2015 - atsjournals.org
Rationale: We have been collecting Burkholderia species bacteria from patients with cystic
fibrosis (CF) for the last 30 years. During this time, our understanding of their multispecies …
fibrosis (CF) for the last 30 years. During this time, our understanding of their multispecies …
[HTML][HTML] An open-label extension study of ivacaftor in children with CF and a CFTR gating mutation initiating treatment at age 2–5 years (KLIMB)
…, GS Sawicki, KW Southern, M Chilvers… - Journal of Cystic …, 2019 - Elsevier
Background KIWI (NCT01705145 ) was a 24-week, single-arm, pharmacokinetics, safety, and
efficacy study of ivacaftor in children aged 2 to 5 years with cystic fibrosis (CF) and a CFTR …
efficacy study of ivacaftor in children aged 2 to 5 years with cystic fibrosis (CF) and a CFTR …
Inhaled hypertonic saline in preschool children with cystic fibrosis (SHIP): a multicentre, randomised, double-blind, placebo-controlled trial
…, J Au, N McDonald, C Prentice, M Chilvers… - The lancet Respiratory …, 2019 - thelancet.com
Background Inhaled hypertonic saline enhances mucociliary clearance, improves lung
function, and reduces pulmonary exacerbations in people with cystic fibrosis older than age 6 …
function, and reduces pulmonary exacerbations in people with cystic fibrosis older than age 6 …
